Prognostic role of physiologic assessment after treatment of coronary in-stent restenosis
- 1Department of Cardiology, University of Szeged
- 2University Heart Center Graz, Medical University of Graz
- 3Heart and Vascular Center, Semmelweis University
Abstract
Background: The optimal management of coronary in-stent restenosis (ISR) remains challenging. Physiologic indices such as quantitative flow ratio (QFR) may improve risk stratification and guide treatment beyond angiography alone. In the present study the diagnostic and prognostic value of QFR in patients with coronary ISR undergoing percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB) or drug-eluting stent (DES) was evaluated.
Methods: We conducted a sub study of the prospective OPEN-ISR trial, including 43 patients (43 lesions) with angiographically documented ISR treated between November 2021 and September 2024. QFR was measured before and immediately after the intervention as well as at 6 months follow-up. The primary endpoints were binary angiographic restenosis and major adverse cardiac events at 6 months.
Results: A total of 43 patients with 43 ISR lesions were included. Post-procedural QFR was 0.94 ± 0.04. At a follow-up of 6 months, binary restenosis occurred in 35% of lesions. Patients with restenosis had significantly lower post-procedural QFR compared to those without (0.91 ± 0.05 vs. 0.95 ± 0.03 respectively; p = 0.05). The rate of reintervention in lesions treated with DES was comparable to those treated with DCB (44% vs. 30% respectively; p = 0.51). A post-procedural QFR threshold of 0.91 discriminated lesions with significantly higher risk of recurrence.
Conclusions: Physiologic assessment after PCI for coronary ISR provides important prognostic information. Suboptimal post-procedural QFR identifies lesions at increased risk of adverse outcomes and may help optimize ISR treatment strategies.
Related
- Development and Population-Based Prognostic Utility Assessment of an ICD-10-CM-Based Prediction Model to Identify Left Ventricular Systolic Dysfunction: Discrimination Performance and Population-Based Evaluation in 83,357 Patients with Acute Coronary Syndrome
- Risk factors for post-PCI restenosis in patients with coronary heart disease and the development and validation of a nomogram prediction model
- Recent advances in coronary in-stent restenosis: a comprehensive narrative review
- Hemodynamic Significance of APEXCT Coronary Angiography Combined With Dynamic CT Myocardial Perfusion Imaging in Assessing Restenosis After Coronary Stenting
- Nomogram for predicting post-percutaneous coronary intervention restenosis in patients with coronary artery disease and diabetes: a retrospective study
BibTeX
@article{janko2026prognostic,
title = {{Prognostic role of physiologic assessment after treatment of coronary in-stent restenosis}},
author = {Laura Krisztina Jankó and Judit Andreka and Zoltan Jambrik and István F. Édes and Péter Kulyassa and Dávid Becker and Béla Merkely and Gabor G. Toth and Zoltan Ruzsa},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = nov,
doi = {10.3389/fcvm.2026.1825149},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1825149/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Prognostic role of physiologic assessment after treatment of coronary in-stent restenosis
AU - Laura Krisztina Jankó
AU - Judit Andreka
AU - Zoltan Jambrik
AU - István F. Édes
AU - Péter Kulyassa
AU - Dávid Becker
AU - Béla Merkely
AU - Gabor G. Toth
AU - Zoltan Ruzsa
PY - 2026
DA - 2026/11/16
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1825149
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1825149/full
AB - Background: The optimal management of coronary in-stent restenosis (ISR) remains challenging. Physiologic indices such as quantitative flow ratio (QFR) may improve risk stratification and guide treatment beyond angiography alone. In the present study the diagnostic and prognostic value of QFR in patients with coronary ISR undergoing percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB) or drug-eluting stent (DES) was evaluated. Methods: We conducted a sub study of the prospective OPEN-ISR trial, including 43 patients (43 lesions) with angiographically documented ISR treated between November 2021 and September 2024. QFR was measured before and immediately after the intervention as well as at 6 months follow-up. The primary endpoints were binary angiographic restenosis and major adverse cardiac events at 6 months. Results: A total of 43 patients with 43 ISR lesions were included. Post-procedural QFR was 0.94 ± 0.04. At a follow-up of 6 months, binary restenosis occurred in 35% of lesions. Patients with restenosis had significantly lower post-procedural QFR compared to those without (0.91 ± 0.05 vs. 0.95 ± 0.03 respectively; p = 0.05). The rate of reintervention in lesions treated with DES was comparable to those treated with DCB (44% vs. 30% respectively; p = 0.51). A post-procedural QFR threshold of 0.91 discriminated lesions with significantly higher risk of recurrence. Conclusions: Physiologic assessment after PCI for coronary ISR provides important prognostic information. Suboptimal post-procedural QFR identifies lesions at increased risk of adverse outcomes and may help optimize ISR treatment strategies.
SN - 2297-055X
ER -